Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹196.79
Market cap: ₹6,386 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.0×Sector 47.3×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Annual General Meeting 3 Promoter Reclassification 2 Management Change 2 Fund Raise 2 Business Update 2 Board Meeting Date 2 Merger & Restructuring 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 19:39 IST NSE

Annual General Meeting

Sun Pharma Advanced Research Company Annual General Meeting

SPARC held its 21st Annual General Meeting on August 10, 2026, via video conferencing. The meeting covered routine business, including adoption of financial statements.

Read the filing ↗

16 Jul 2026 20:49 IST BSE

Annual General Meeting

Sun Pharma Advanced Research Company Annual General Meeting

SPARC scheduled its 21st AGM for August 10, 2026, via video conference. Agenda includes adopting FY26 financials and appointing Anil Kumar Raghavan as MD and CEO.

Read the filing ↗

6 Jul 2026 12:36 IST NSE

Annual General Meeting

Sun Pharma Advanced Research Company Annual General Meeting

The 21st AGM of Sun Pharma Advanced Research Company will be held on 10 Aug 2026 via video conference. Electronic voting is open until 3 Aug 2026.

Read the filing ↗